[HTML] frontiersin.org

[HTML][HTML] The potential role of the intestinal micromilieu and individual microbes in the immunobiology of chimeric antigen receptor T-cell therapy

ML Schubert, R Rohrbach, M Schmitt… - Frontiers in …, 2021 - frontiersin.org
Cellular immunotherapy with chimeric antigen receptor (CAR)-T cells (CARTs) represents a
breakthrough in the treatment of hematologic malignancies. CARTs are genetically …
被引用次数：26 相关文章

The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy.

ML Schubert, R Rohrbach, M Schmitt… - Frontiers in …, 2021 - europepmc.org
Cellular immunotherapy with chimeric antigen receptor (CAR)-T cells (CARTs) represents a
breakthrough in the treatment of hematologic malignancies. CARTs are genetically …

The potential role of the intestinal micromilieu and individual microbes in the immunobiology of chimeric antigen receptor T-cell therapy

ML Schubert, R Rohrbach, M Schmitt… - 2021 - katalog.ub.uni-heidelberg.de
In this review, we will provide a comprehensive overview of the principles of CD19-CART
immunotherapy and major aspects of the gut microbiome and its modulators that impact …
[HTML] nih.gov

[HTML][HTML] The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy

ML Schubert, R Rohrbach, M Schmitt… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Cellular immunotherapy with chimeric antigen receptor (CAR)-T cells (CARTs) represents a
breakthrough in the treatment of hematologic malignancies. CARTs are genetically …

The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy

ML Schubert, R Rohrbach, M Schmitt… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Cellular immunotherapy with chimeric antigen receptor (CAR)-T cells (CARTs) represents a
breakthrough in the treatment of hematologic malignancies. CARTs are genetically …